Article
Study protocol: Effectiveness of the maternal RSVpreF vaccine by virus type
2025-12-05
Abstract excerpt
<h4>Background: </h4> Respiratory syncytial virus (RSV) is a virus with two antigenic types, A and B, that cause significant morbidity and mortality in infants globally. A recently developed maternal vaccination based on the prefusion F protein (“RSVpreF”) could have a significant impact on disease burden, if introduced globally. Whether or not the effectiveness of this vaccine is affected by circulating viral gen...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6c76ee4e-f99a-51c8-92fc-7a42bb5aedd5
- DOI
- 10.12688/wellcomeopenres.24371.1
